There were 1,706 press releases posted in the last 24 hours and 442,636 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image